FDA Recalls Zantac, Due to Probable Carcinogen Ingredient
FDA Recalls Zantac, Due to Probable Carcinogen Ingredient

FDA Recalls Zantac, Due to Probable Carcinogen Ingredient

Business Wars Daily

02.04.2020 • 6 Min.

Today is Thursday, April 2, and we’re looking at Zantac vs. Pepcid. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.